CLINICAL_TRIALS
trial_result
· 2008-12-18
Clinical Trial Update: A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea [Phase 2]
Summary
A Phase 2 study evaluating Atralin (tretinoin 0.05% gel) for rosacea has completed, assessing safety and efficacy in affected patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Coria Laboratories, Ltd. | Conditions: Rosacea | Phase 2 | Status: COMPLETED